amobarbital has been researched along with Porphyria in 3 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
PLUM, CM | 1 |
COWGER, ML | 1 |
LABBE, RF | 1 |
SEWELL, M | 1 |
Rees, HA | 1 |
Goldberg, A | 1 |
Cochrane, AL | 1 |
Williams, MJ | 1 |
Donald, KW | 1 |
3 other studies available for amobarbital and Porphyria
Article | Year |
---|---|
[Porphyria following trinoal and pentymal therapy].
Topics: Amobarbital; Animals; Barbiturates; Porifera; Porphyrias | 1954 |
Oxidative metabolism of tissue culture cells in the presence of porphyriainducing drugs.
Topics: Amides; Amobarbital; Carbohydrate Metabolism; Cell Respiration; Energy Metabolism; Humans; Metabolis | 1963 |
Renal haemodialysis in porphyria.
Topics: Adult; Amobarbital; Blood Chemical Analysis; Chlorpromazine; Female; Humans; Male; Mental Disorders; | 1967 |